1. News & Events
  2. Newsroom
  3. FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use

FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use

Share:

EmailFacebookLinkedInXWhatsAppShare
March 15, 2016

The U.S. Food and Drug Administration (FDA) has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States. Read more at Vanderbilt University.